Bristol Myers Squibb buys San Diego cancer therapy company for $4.8B
It's unclear what the Bristol Myers Squibb deal with San Diego's Mirati Therapeutics means for the local workforce.
Source: sandiegouniontribune.com
Page 3 - Charles Baum News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Charles Baum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Charles Baum Today - Breaking & Trending Today
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value Right Acquisition Brings KRAZATI® , a...
Source: marketscreener.com
3 Under-the-Radar Biotech Stocks to Buy in 2023
All three biotech companies focus on oncology therapies.
Source: fool.com
Why Shares of Mirati Therapeutics Are Jumping Wednesday
The company replaced its CEO and reported strong revenue growth.
Source: fool.com
Premium Times Publisher joins Poynter Media Transformation Challenge as first African Fellow
The fellowship, Mr Olorunyomi said "looks potentially helpful for the future we seek to plot at the Premium Times and Centre for Journalism..
Source: premiumtimesng.com